COVID-19: Can India vaccinate all adults in 4 months?

Confronting head-on the vexed pricing of COVID -19 vaccines

It would cost anything between Rs 13,821 crore to Rs 1,10,568 crore to vaccinate the 20-44 age population

Viva Cuba for its vaccine revolution

Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world    

Covaxin has not got emergency use approval from WHO since 6 months. Know the process here

The approval is stuck in the final fifth stage of the process when clinical data on safety, efficacy, quality and risk management plan are evaluated

Bharat Biotech COVID-19 vaccine claimed to have 80.6% efficacy

'Shot well tolerated in participants; adverse events balanced between vaccine and placebo arms of the trial'    

WHO finally gives emergency use nod for Covaxin

Those administered indigenous Indian vaccine against COVID-19 can now travel abroad unhindred 

Bhopal Covaxin trial participants allege side-effects, irregularities

Bhopal-based rights group writes to PM and Union health minister, demanding that ongoing Covaxin trial be halted there

Covid-19 vaccination drive rolled out in Punjab and Himachal Pradesh, skepticism lingers

Some ASHA workers refused to get the jab on Saturday 

The world may soon get a vaccine against Chikungunya

A multi-country Phase II / III clinical trial of a vaccine led by the International Vaccine Institute in partnership with Bharat Biotech …

Moderna’s brazen patent grab on a COVID-19 jab

The US administration is finally putting its foot down on the appropriation of public research by drug firms  

India readies for COVID-19 vaccination but vexed questions on the solution remain

The risks the country needs to prepare for, precautions it needs to take, the logistics required and, above all, the implications of it all for …

Bharat Biotech’s vaccine, Covaxin not as effective as Serum Institutes of India’s Covishield

Study led by National Centre for Biological Sciences intended to shape future vaccine strategies by offering insights into the immunity acquired …

Bharat Biotech will begin clinical trials of Covaxin on 2-18 age group

The clinical trials will be conducted to evaluate Covaxin’s safety and efficacy on a population group left out of India’s current …

COVID-19 vaccines for all: India’s supply story deconstructed

Vaccination presents a way out of the COVID-19 mess India has landed in; but jabs are in short supply and there’s no clarity …

Vaccine production in South Africa: how an industry in its infancy can be developed

Only if investment is increased, sustained, and backed by political commitment, will the country have sufficient vaccine production capacity

COVID-19: Expert committee approves Covaxin for children aged 2-18 years

No data on clinical trials of Bharat Biotech vaccine on children available publicly yet

Norway deaths, social media rumours: Why healthcare workers in Bihar are staying away from vaccines

Nearly 40% healthcare workers scheduled for first 3 days give the jab a miss

COVID vaccines: How to make sense of reports on their effectiveness

Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants

Delaying the second COVID-19 vaccine dose: A medical expert answers key questions

The uncertainty is around how long the protective effect of the first dose will last without a second shot

Bharat Biotech COVID-19 vaccine gets govt panel nod for emergency use: Experts express concern

Recommendation to drug controller for emergency approval to India’s indigenous product against COVID-19

COVID-19 Vaccine Watch: India tops number of COVID-19 vaccine doses arranged from manufacturers

However, in terms of the proportion of the population that can be vaccinated with these doses, Canada leads the charts

First ‘Made in India’ cervical cancer vaccine in offing

Vaccine to be launched after adequate doses manufactured for distribution

Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates

Share of population completely vaccinated grew just 5 percentage points since April

Where are the vaccines for UP’s May 1 COVID-19 vaccination drive

There is extreme shortage of COVID-19 vaccines in India’s largest state and its government is facing problems in procuring them

Centre signs deal with Serum Institute for 11 million COVID-19 vaccine doses: Sources

Talks on with Bharat Biotech; no official statement from government or manufacturers yet